MACTER Pharmaceuticals: Major
Health Technology
Mkt Cap
12.4B
P/E (TTM)
15.17
EPS
16.95
ROE
21.95%
Div Yield
1.41%
About
Macter International Ltd. engages in the manufacture and market of pharmaceutical products. Its products include pharmaceutical, biological, and consumer products. The company was founded on June 23, 1992 and is headquartered in Karachi, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 10.36B | 7.97B | 6.93B | 5.61B | 5.37B | |
| Gross Profit | 4.57B | 3.25B | 2.78B | 2.44B | 2.15B | |
| Net Income | 776.43M | 406.69M | 357.13M | 291.82M | 225.98M | |
| EPS | 16.95 | 8.88 | 7.80 | 6.60 | 5.77 | |
| ROE | 23.69% | 14.52% | 14.18% | 16.31% | 20.11% | |
| ROA | 12.95% | 7.89% | 7.52% | 7.02% | 5.83% | |
| Gross Margin | 44.09% | 40.77% | 40.08% | 43.47% | 39.99% | |
| Net Margin | 7.49% | 5.10% | 5.16% | 5.20% | 4.21% | |
| Current Ratio | 1.84 | 1.85 | 1.85 | 1.77 | 1.27 | |
| DPS | 3.80 | 2.25 | 1.08 | 3.21 | 3.90 | |
| Free Cash Flow | -283.64M | 26.75M | -353.71M | 257.10M | 282.72M |